SecBot SecBot
8-K ·Filed Jun 17, 2026

VTGN

Vistagen Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago SEC0001628280-26-043989
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Routine board refresh, no immediate trading signal. Monitor for any subsequent board composition changes or strategic shifts, but this filing alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$0.6702
T+0 close · Jun 17, 2026 · via day close
Latest settled
−63.71%
T+60 · $0.2432
Vs SPY
−65.61%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 18 $0.6702entry
  2. T+1 · 5mo ago −4.52%α −4.21% · $0.6399
  3. T+5 · 5mo ago −8.00%α −6.33% · $0.6166
  4. T+20 · 4mo ago −64.19%α −64.72% · $0.2400
  5. T+60 · 2mo ago −63.71%α −65.61% · $0.2432
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two board members, Margaret FitzPatrick and Dr. Joanne Curley, notified Vistagen they will not stand for re-election at the 2026 Annual Meeting. Both will continue serving until the end of their terms. This is a routine board transition with no C-suite departures or red flags.

Key Facts

  • Margaret FitzPatrick notified on June 16, 2026 of decision not to stand for re-election.
  • Dr. Joanne Curley notified on June 17, 2026 of decision not to stand for re-election.
  • Both will continue as directors until the end of their terms at the 2026 Annual Meeting.
  • No replacements named; no CEO/CFO departure or resignation language.

Financial Impact

No financial impact disclosed.

Risk Factors

  • Potential loss of board expertise if replacements are not equally qualified.
  • Minimal, no material risk to operations or strategy.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-043989
Document: 0001628280-26-043989-index-headers.html0001628280-26-043989
Document: 0001628280-26-043989-index.html0001628280-26-043989
Document: 0001628280-26-043989.txt0001628280-26-043989

Track record

21 reports on VTGN

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +20.40% at T+5 after the Jun 11, 2026 report. 1 of 3 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $0.1843 Now $0.1800 −2.33% settles Nov 24
  2. Nov 13, 20263d ago Press Release Neutral 5/10 Entry $0.1805 Now $0.1800 −0.28% settles Nov 23
  3. Nov 9, 20267d ago 8-K Neutral 4/10 Entry $0.1844 to $0.1843 Now $0.1800 −2.39% ▼ −0.05% +1.64% vs SPY
  4. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $0.1844 to $0.1843 Now $0.1800 −2.39% ▼ −0.05% +1.64% vs SPY
  5. Oct 30, 202617d ago 8-K Bearish 6/10 Entry $0.1675 to $0.1844 Now $0.1800 −7.46% ▼ −10.09% −10.01% vs SPY
  6. Oct 9, 20265w ago 8-K Neutral 3/10 Entry $0.2300 to $0.2000 Now $0.1800 −21.74% ▼ −13.04% −11.55% vs SPY
  7. Sep 25, 20267w ago 8-K Neutral 4/10 Entry $0.2700 to $0.2800 Now $0.1800 −33.33% ▲ +3.70% +3.93% vs SPY
  8. Sep 24, 20267w ago 8-K Neutral 4/10 Entry $0.2950 to $0.2826 Now $0.1800 −38.98% ▼ −4.20% −3.79% vs SPY
  9. Sep 24, 20267w ago Press Release Neutral 4/10 Entry $0.2950 to $0.2826 Now $0.1800 −38.98% ▼ −4.20% −3.79% vs SPY
  10. Aug 14, 202613w ago 8-K Bearish 6/10 No price data
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 1m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 17, 2026